Arksa Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 11 Months
About Arksa Pharma
Arksa Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 March 2023 (One year and 11 months 3 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Reshma Noronha, Ruark Denoronha, Gordon Denoronha, and One other member serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U46497MH2023PTC398578
-
Company No.
398578
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Mar 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Who are the key members and board of directors at Arksa Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ruark Denoronha
|
Managing Director | 09-Mar-2023 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Reshma Noronha
|
Director | 09-Mar-2023 | Current |
|
Gordon Denoronha
|
Nominee Director | 09-Mar-2023 | Current |
|
Krasia Noronha
|
Director | 18-Dec-2023 | Current |
Financial Performance of Arksa Pharma.
Enhance accessibility to Arksa Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arksa Pharma?
Unlock access to Arksa Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Reonvision Wellness Private LimitedRuark Denoronha is a mutual person
-
Reonvision LlpReshma Noronha, Ruark Denoronha and 1 more are mutual person
-
Tapinga Technologies Private LimitedReshma Noronha, Ruark Denoronha and 1 more are mutual person
-
Playcloud Technologies Private Limited
Reshma Noronha, Ruark Denoronha and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Arksa Pharma?
Unlock and access historical data on people associated with Arksa Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arksa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arksa Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.